BACKGROUND: Fatty liver disease is a common condition linked to metabolic syndrome, cardiovascular diseases, and liver cirrhosis, and timely, accurate diagnosis is crucial. In clinical studies, incorporating deep learning models often faces the chall...
BACKGROUND: The global rise of metabolic associated fatty liver disease reflects the urgent need for accurate, noninvasive diagnostic approaches. The invasive nature of liver biopsy and the limited sensitivity of ultrasound in detecting early steatos...
INTRODUCTION: Early detection of carotid plaque prevents stroke and myocardial infarction. Individuals with fatty liver might be at an increased risk of developing carotid plaque, yet limited access to carotid artery ultrasound underscores the need f...
Emerging evidence links metabolic dysfunction-associated fatty liver disease (MAFLD) with increased all-cause and circulatory system disease (CSD) mortality in adults, yet survival machine learning studies are limited. This study analyzed 4415 NHANES...
OBJECTIVE: With the global increase in obesity rates and lifestyle changes, metabolic dysfunction-associated steatotic liver disease (MASLD) has become a prevalent chronic liver disorder, affecting approximately 25% of the global population. This dis...
BACKGROUND: Metabolic dysfunction associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease worldwide and affects >25% in the United States population. We hypothesized that clinical features present in electronic health r...
Cardiovascular disease (CVD) remains the most common cause of death worldwide. Carotid plaque is an indicator of subclinical CVDs. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a risk factor for atherosclerotic CVDs. We aimed to...
BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease worldwide. Progression from simple metabolic dysfunction-associated steatotic liver (MASL) without necro-inflammation to...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease worldwide, affecting over 30% of the global general population. Its progressive nature and association with other chronic diseases make...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.